Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin for Chronic Pain
NCT04903002Phase 3Active, not recruiting
- Sponsor
- Memorial University of Newfoundland
- Start
- Apr 2022
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in chronic pain, sponsored by Memorial University of Newfoundland. Started Apr 2022; status: active, not recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT04903002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04903002.